Bill of Lading No.
Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
CHSL373087930MAA
2021-12-21
848410 CACTUS WELLHEAD LLC MADRAS INDUSTRIAL PRODUCTS TOTAL 4 PACKAGES RING JOINT METALLIC GASKET HS CODE 84841090 SHIPPER S INVOICE AND DATE 2021-22 E305 DT 11.10.2021 SHIPPER S SHIPPING BILL AND DATE 5260054 DT 12.10.2021 PO NUMBER TRP0033619 IEC.NO 0488026326 NET WEIGHT 3120 KGS FREIGHT COLLECT<br/>
INDIA
UNITED STATES
54201, COLOMBO HARBOR
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3392
KG
4
PKG
0
USD
291220CNICB20015120-02
2021-01-14
282690 CHI NHáNH LONG AN C?NG TY TNHH SURTEC VI?T NAM MADRAS FLUORINE PRIVATE LTD Potassium Fluoborate substances. CAS No: 14075-53-7. Used to produce surface treatment compositions. New 100%;Chất Potassium Fluoborate. CAS No: 14075-53-7. Dùng để sản xuất chế phẩm xử lý bề mặt. Hàng mới 100%
INDIA
VIETNAM
CHENNAI (EX MADRAS)
CANG CAT LAI (HCM)
4325
KG
200
KGM
955
USD
HLCUMA3200139834
2020-03-30
281119 ADVANCE RESEARCH CHEMICALS INC MADRAS FLUORINE PRIVATE LTD HEXAFLUOROTITANIC 16 X 1250 KG IBC WITH COMPOSITE PALLET(TOTALLY 16 IBCS) HEXAFLUOROTITANIC ACID 60% (CORROSIVE LIQUID ACIDIC INORGANIC N.O.S) UN 3264,IMO 8,PKG II INV NO E081/2019-20 DT.27-01-2020 BUYERS ORDER NO & DATE 2005-00-00001 DT.13-01-2020 SB NO
INDIA
UNITED STATES
41352, CORYTON
5301, HOUSTON, TX
20936
KG
16
PCS
0
USD
067AX28821
2020-12-04
300490 NELPA LIFESCIENCES INC
SWASTIK PHARMACEUTICALS PHARMACEUTICAL PRODUCTS CALMSAPH ALUMINA AND MAGNESIA 31700PCS 317CTNS OTHERS CALMSAPH ALUMINA AND MAGNESIA
INDIA
PHILIPPINES
Port of Manila
Port of Manila
3630
KG
31700
Proof litre
3804
USD
2021/211/C-18672
2021-04-21
300449 FARMEDICAL S R L AAVIS PHARMACEUTICALS MIDAZOLAM FM (MIDAZOLAM 5GM/ML); Medicaments (Excluding Goods Of Heading 30.02, 30.05 Or 30.06) Consisting Of Mixed Or Unmixed Products For Therapeutic Or Prophylatic Uses, Put Up In Measured Doses (Including Those In The Form Of Transdermal Administration System) Or In Forms Or Packings For Retail Sale, For Human Use
INDIA
BOLIVIA
MANDSAUR
VERDE
1116
KG
973
CAJA DE CARTON
88264
USD
MEDUM6054636
2021-02-11
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 9 PALLET CONTAINING 526 CA RTONS PHARMACEUTICALS AS UNDER PRAVASTATIN SODIU M TAB 20MG 90 S NDC CODE:6 8462019690 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S NO.:3004.90.92.20 ANDA NO .:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMICPOTASSIUM CL ER CAPS 10MEQ (750MG) 500 S NDC CODE:68462035705 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.:3004.9 0.92.90 ANDA NO.: 20 2868 T HERAPEUTICE USE: -TREATMEN T OR PREVENTION OF HYPOKAL EMIA 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO.F20087 001593 DT. 07.01.2021 F200 87001594 DT. 07.01.2021 N ET WT: 1008.367 FREIGHT PR EPAID THE TEMPERATURE TO BE SET AT 20 DEGREES CELC IUS IN ACCORDANCE W ITH SHI PPER S INSTRUCTIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1863
KG
9
PKG
0
USD
MEDUMG767350
2020-11-24
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 10 PALLET CONTAINING 457 C ARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPS 10MEQ (750MG) 100 S NDC C ODE:68462035701 FDA PRODUC T CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AND A NO.:202868 THERAPEUTICE USE: -TREATMENT OR PREVENT ION OF HYPOKALEM
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1997
KG
10
PKG
0
USD
MEDUMV727836
2020-09-18
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 24 PALLETS CONTAINING 408 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3619
KG
24
PKG
0
USD
MEDUMV100604
2020-08-06
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 36 PALLETS CONTAINING 823 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AN DA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVE NTION OF HYPOKALE
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6071
KG
36
PKG
0
USD
MEDUMV826000
2020-09-26
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 24 PALLETS CONTAINING 457 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3620
KG
24
PKG
0
USD
MEDUMG224964
2020-10-19
651400 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 10 PALLETS 581 CARTONS PHA RMACEUTICALS AS UNDER POTA SSIUM CL ER CAPS 10MEQ (75 0MG) 500 S NDC CODE:684620 35705 FDA PRODUCT CODE NO. : 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDANO.: 2 02868 THERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA PO
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2130
KG
10
PKG
0
USD
MAEU218449289
2022-06-08
620600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 14 PALLETS 761 CARTONS PH ARMACEUTICALS AS UNDER ESOM EPRAZOLE MAG DR CAPS 20MG 90 S NDC CODE:68462039090 FDA PR ODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 A NDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL H YPERSECRETORY CONDITIONS, INC LUDING ZOLLINGER-ELLISON SYN DROME ESOMEPRAZOLE MAG DR C APS 40MG 90 S NDC CODE:684620 39190 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004 .90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOL E MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR T HE LONG-TERM TREATMENT OF PA THOLOGICAL HYPERSECRETORY CO NDITIONS, INCLUDING ZOLLINGER -ELLISON SYNDROME COMMERCI AL & CUSTOM INVOICE NO. F2238 7000139 DT. 29.04.2022 S/BILL NO: 4006221 DT: 29/04/2022 NET WT: 756.17 KGS 14 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3034
KG
14
PKG
0
USD
MEDUMA940102
2021-02-11
624900 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 27 PALLET CONTAINING 808 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC URSODIOL TABS 500MG 100 S NDC C ODE:68462047401 FDA PRODUCT CODE NO.:63 N C A 25 H. T. S NO.:3004.49.00 .10 ANDA NO.: 90-8 01 THER APEUTICE USE: - FOR THE TR EATMENT O F PATIENTS WITH P RIMARY BILIARY CIRRHOSIS T HE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHO SIS 02 DATA LOGGERS HUMI DITY:65% S ET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2005 2004008 DT. 08.01.2021 NE T WT: 5607.01 FREIGHT PR EPAID THE TEMPE RATURE T O BE SET AT +20 DEGREE CEL CIUS IN ACCORDANCE WITH SH IPPER INSTRUCTIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6417
KG
27
PKG
0
USD
KWLD70330040536
2021-02-06
624900 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 01 X 40 RF CNTR TOTAL 41 (FORTY ONE) PACKAGESTS 500MG 500 S NDC CODE68462019005 FDA PRODU CT CODE NO.-62 G C A 49 H. T. S NO.<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8718
KG
41
PKG
0
USD
MAEU216792167
2022-03-24
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 3858 CARTONS PACKED IN 46 PALLETS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC PRAMIPEXOLE TABS 1M G 90 S NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S DI SEASE PRAMIPEXOLE TABS 0.25MG 90 S NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DIS EASE OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AGE NT OLMESARTAN MEDOXOMIL TABLE TS 5MG 30 S NDC CODE:68462043 630 FDA PRODUCT CODE NO.: 62C CA68 H. T. S NO.: 3004.90.922 0 ANDA NO.: 203281 THERAPEUTI CE USE: -TREATMENT OF HYPERTEN SION, ALONE ORWITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S N DC CODE:68462047205 FDA PRODU CT CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA NO. : 206391 THERAPEUTICE USE: - MEDICATION USED FOR HEART FAIL URE, HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART URSODIOL TABS 2 50MG 100 S NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 90-801 THERA PEUTICE USE: - FOR THE TREATME NT OF PATIENTS WITH PRIMARY B ILIARY CIRRHOSIS GABAPENTIN TABLETS 600MG 100 S NDC CODE: 68462012601 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICON VULSANT AGENT NET WT : 10,381 .95 KGS GROSS WT : 12,463.41 KGS COMMERCIAL & CUSTOM INVOI CE NO. F22252005778 DT. 23.02 .2022 F22252005780 DT. 23.02. 2022 SB NO.: 8492215 DT.: 24/ 02/22 SB NO.: 8492102 DT.: 24 /02/22 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12464
KG
46
PKG
0
USD
MAEU216471582
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 49 PACKAGE CONSISTING OF 3295 CARTONS PH ARMACEUTICALS AS UNDER NAPROX EN TABLETS 500MG 100 S NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLET S 25MG 60 S NDC CODE:68462010 860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVULSA NT GABAPENTIN TABLETS 600MG 5 00 S NDC CODE:68462012605 FD A PRODUCT CODE NO: 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.:91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE 03 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO. F222520055 51 DT. 05.02.2022 F2225200555 2 DT. 05.02.2022 F22252005553 DT. 05.02.2022 TOTAL NET.WT. :11610.44KGS SBILL NOS DT. 8053058 07-FEB-2022 80532 61 07-FEB-2022 8053408 07- FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
13478
KG
49
PKG
0
USD
MAEU214106719
2021-11-18
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LTD 1X 40 REEFER FCL 41 PALLETS CONSISTING OF 3143 CARTONS PH ARMACEUTICALS AS UNDER TELMIS ARTAN TABLETS 20MG 30 S NDC C ODE:68462019930 FDA PRODUCT C ODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO. :090032 THERAPEUTICE USE: IN DICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC INDOMETHACIN C APS 25MG 100 S NDC CODE:68462 040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 30 04.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLAM ATORY ROPINIROLE TABS 0.5MG 1 00 S NDC CODE:68462025401 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM OXCARBAZEPINE TABLETS 300MG 100 S NDC CODE:684620 13801 FDA PRODUCT CODE NO. :-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT LITHIUM CA RBONATE CAPS 150MG 100 S NDC CODE:68462022001 FDA PRODUC T CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT LA MOTRIGINE TABLETS FOR OS(CD)25 MG100 S NDC CODE:68462022901 FDA PRODUCT CODE NO.:-61 M C A 38 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:-ANTICONVULSAN T 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200379 1 DT. 22.10.2021 SBILL NO DT 5495765 23.10.20 21 TOTAL GR.WT.:10911.61KGS TOTAL NT.WT.:8849.48KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10911
KG
41
PKG
0
USD
MEDUMA708665
2021-01-28
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 13 PALLET CONTAINING 840 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC TOPIRAMATE TABLETS 25MG 60 S NDCCODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.4 9.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONV ULSANT ZONISAMIDE CAPSULE S 50MG 100 S NDC CODE:6846 2012901 FDA PRODUCT CODE N O.:-61 M C E 44 H. T.S NO .3004.49.00.20 ANDA NO.:-7 7-651 THERAP EUTICE USE:-AN TISEIZURE DRUG 01 DATA LO GGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREESCO MMERCIAL & CUSTOM INVOICE NO. F2005200374 4 DT. 22.12 .2020 NET WT:2,083.02 F REIGHT PREPAID THE TEMP ERATURE TO BE SET AT +20 D E GREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCTION S ON BEHALF OF : GLENMARK PHARMACEUT ICALS LIMITED N AME ACCOUNT : GLENMARK PHA RMACEUTICALS LIMITED<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2550
KG
13
PKG
0
USD
MAEU608910666
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 19 PALLETS CONSISTING OF1600 C ARTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500 MG 500 S NDC CODE: 6846201 9005 FDA PRODUCT CODE NO.: -62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAPSULES 40MG 30 S NDC CODE:68462039730 FD A PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX D ISEASE MUPIROCIN CREAM 2% 15GM NDC CODE: 68462056417 FDA PRODUCT CODE NO.: 61G CJ82 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 201587 THE RAPEUTICE USE: - TOPICAL ANT I-BACTERIAL MUPIROCIN CREAM 2% 30GM NDC CODE: 684620 56435 FDA PRODUCT CODE NO. : 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 20158 7 THERAPEUTICE USE: - TOPI CAL ANTI-BACTERIAL 02 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2225200 5541 DT. 05.02.2022 F2225200 5539 DT. 04.02.2022 TOTAL NE T WT.:3982.30KGS SBILL NO DT. 8023698 06-F EB-2022 8023636 06-FEB- 2022 NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4880
KG
19
PKG
0
USD
MAEU216273001
2022-03-02
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 CONTAINER 19 PALLETS 19 P ALLETS CONSISTING OF 947 CARTO NS 1X40 PART OF FCL REEFER PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 100 S NDC CODE:6846201900 1 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY , ANALGESIC NA PROXEN TABLETS 500MG 500 S NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY, AN ALGESIC PRAMIPEXOLE TABS 1MG 90 S NDC CODE:6 8462033390 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 T HERAPEUTICE USE: USED IN PARKINSON#S DISEASE GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT A GENT 01 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520053 54 DT. 28.01.2022 F2225200535 6 DT. 28.01.2022 SBILL NOS DT. 7836397 29-JAN-20 22 7835871 29-JAN-2022 T OTAL GR.WT.: 6,067.50 KGS TOT AL NT.WT: 5,359.75 KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6067
KG
19
PKG
0
USD
MEDUM6528407
2021-03-13
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 6 PALLET CONTAINING 211 CA RTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 500 S NDCCODE:68462 019005 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC NAPROXEN TABLETS 500MG 5 00 S NDCCODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.9 0.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFL AMMATORY,ANALGESIC NAPROX EN TABLETS 500MG 500 S NDC CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.90.92.40 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY ,ANALGESIC DATA LOGGERS H UMIDITY:65% SET TEMPERATUR E : +20 DEGREES COMMERCIA L & CUSTOM INVOI CE NO. F20 052004434 DT. 06.02.2021 F 20052004437 DT. 06.02.2021 F20052004438 DT. 06.02.2021 NET WT:848.520 FREIGH T PREPAID THE TEM PERATU RE TO BE SET AT +20 DEGREE CELCIUS IN ACCORDANCE WIT H SHIPPER INSTRUCTIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
944
KG
6
PKG
0
USD
MAEU217679575
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PALLETS 97 CARTONS PHAR MACEUTICALS AS UNDER LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO. :206498 THERAPEUTICE USE: -US ED TO TEMPORARILY RELIEVE PA IN AND ITCHING ASSOCIATED WIT H SKIN COMMERCIAL & CUSTOM INVOICE NO. F22252006369 DT. 31.03.2022 NET WT: 908.17 K GS 00 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1065
KG
4
PKG
0
USD
MEDUMA846093
2021-02-08
600700 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 8 PALLET CONTAINING 241 CA RTONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMEN T JAR 5% 50GM NDC CODE:684 62041827 FDA PRODUCT CODE NO.:60Q C J 07 H. T. S NO .:3004.49.00.50 ANDA NO. :2 06498 THERAPEUTICE USE: -U SED TO TEMPORARILY RELIEVE PAIN AND ITCHING ASSOCIAT ED WITHSKIN NAPROXEN TAB LETS 500MG 500 S NDC CODE: 68462019005 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY,ANAL GESIC DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2005 2003888 DT. 30.12.2020 F20 052003893 DT. 31.12.2020 NET WT: 2101.740 FREIGHT P REPAID THE TEMPERATURE TO BE SET AT +20 DEGREE CELC IUS IN ACCORDANCE WITH SHI PPER INSTRUC TIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2380
KG
8
PKG
0
USD
MAEU914132405
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 42 PALLETS 2220 CARTONS P HARMACEUTICALS AS UNDER LIDOC AINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRO DUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AND A NO.:206498 THERAPEUTICE USE : -USED TO TEMPORARILY RELIEV E PAIN AND ITCHING ASSOCIATE D WITH SKIN LIDOCAINE OINTM ENT TUBE 5% 35.44GM NDC CODE: 68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:2064 98 THERAPEUTICE USE: -USED T O TEMPORARILY RELIEVE PAIN AN D ITCHING ASSOCIATED WITH SKI N CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:684620297 92 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.4 0.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. THEOPHYLLINE ER TABS 3 00MG 100 S NDC CODE:684620721 01 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS A RE INDICATED FOR THE TREATME NT OF THE SYMPTOMS AND REVER SIBLE AIRFLOW OBSTRUCTION ASS OCIATED WITH CHRONIC ASTHMA A ND OTHER CHRONIC LUNG DISEASE S, E.G., EMPHYSEMA AND CHRON IC BRONCHITIS LITHIUM CARBO NATE CAPS 300MG 1000 S NDC CO DE:68462022110 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT VERAPAMIL H CL ER TABS 120MG 100S NDC COD E:68462029201 FDA PRODUCT COD E NO.: 62 O C B 13 H. T. S N O.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - A NGINA LITHIUM CARBONATE ER TABS 450MG 100 S NDC CODE:684 62022401 FDA PRODUCT CODE NO. : 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-616 THERAPEUTICE USE: - INDICAT ED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER . BIPOLAR DISORDER, MANIC (D SM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, I N THE OLDER DSM-II TERMINOLOG Y. ALSO INDICATED AS A MAINT ENANCE TREATMENT FOR INDIVIDU ALS WITH A DIAGNOSIS OF BIPO LAR DISORDER. MAINTENANCE THE RAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISH ES THE INTENSITY OF THOSE EPI SODES WHICH MAY OCCUR. VER APAMIL HCL ER TABS 240MG 500 S NDC CODE:68462026005 FDA PR ODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 A NDA NO.:-78-906 THERAPEUTICE USE:-ANGINA OLMESARTAN MED OXOMIL TABLETS 20MG NDC CODE: 68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3 004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - TREATMEN T OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE A GENTS, TO LOWER BLOOD PRESSUR E VERAPAMIL HCL ER TABS 120 MG 100S NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-700 THERAP EUTICE USE: - ANGINA LITHI UM CARBONATE CAPS 300MG 100 S NDC CODE:68462022101 FDA PRO DUCT CODE NO.:-61 N C E 37 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 79 -139 THERAPEUTICE USE:-ANTIMANIC AGENT ZOLM ITRIPTAN TABLETS 5MG 3 S NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO .: 201779 THERAPEUTICE USE: - ANALGESIC/ HUMAN - RX/SINGL E INGREDIENT / PROMPT RELEAS E TABLETS / ZOLMITRIPTAN (ANA LGESIC) COMMERCIAL & CUSTOM I NVOICE NO. F22252006340 DT. 3 1.03.2022 F22252006350 DT. 31 .03.2022 F22252006367 DT. 31. 03.2022 F22252006372 DT. 31.0 3.2022 F22252006377 DT. 31.03 .2022 F22252006380 DT. 31.03. 2022 S/BILL NO: 9496822 DT: 05-APR-22 S/BILL NO: 9496828 DT: 05-APR-22 S/BILL NO: 94 97545 DT: 05-APR-22 S/BILL NO : 9496646 DT: 05-APR-22 S/BI LL NO: 9496820 DT: 05-APR-22 S/BILL NO: 9496826 DT: 05-AP R-22 NET WT: 9,414.21 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11501
KG
42
PKG
0
USD
MAEU216329742
2022-03-02
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 44 PALLET S CONSISTING OF2477 CARTONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004. 49.00.50 ANDA NO.:206498 T HERAPEUTICE USE: -USED TO TE MPORARILY RELIEVE PAIN AND I TCHING ASSOCIATED WITH SKIN OMEPRAZOLE DR CAPSULES 40M G 90 S NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAP EUTICE USE: - TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE VERAPAMIL HCL E R TABS 240MG 500 S NDC CODE: 68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE :-ANGINA TOPIRAMATE TABLET S 50MG 1000 S NDC CODE:68462 015310 FDA PRODUCT CODE NO .:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-AN TICONVULSANT ROPINIROLE TABS 0.25MG 100 S NDC CODE:684 62025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:- TREATMENT OF PARKINSONISM GABAPENTIN TABLETS 800MG 500 S NDC CODE: 68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULS ANT AGENT NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CUS TOM INVOICE NO.& F22252005384 DT. 29.01.2022 F22252005388 DT. 29.01.2022 F22252005397 DT. 29.01.2022 F22252005376 DT. 29.01.2022 F22252005392 DT. 29.01.2022 TOTAL NET W T.:10695.27KGS SB NO & DATE ON BL 7911492 01-FEB-2022 7911445 01-FEB-2022 7911424 01-FEB-2022 7911407 01-FEB -2022 7910960 01-FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12093
KG
44
PKG
0
USD
MAEU218682322
2022-06-22
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 1996 CART ONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT JAR 5% 5 0GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTICE USE: -USED TO TEMPORARILY RE LIEVE PAIN AND ITCHING ASSOC IATED WITH SKIN HEATHER NOR ETHINDRONE 0.35MG 84 NDC CODE :68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO .: 3006.60.00.00 ANDA NO.:90 -454 THERAPEUTICE USE: PREVE NTION OF PREGNANCY. NORETHI NDRONE 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. FELODIPINE ER TABS 2.5MG 100 S NDC CODE: 68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREATME NT OF HYPERTENSION TOPIRAM ATE TABLETS 100MG 1000 S NDC CODE:68462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22352000 718 DT. 26.05.2022 F223520007 19 DT. 26.05.2022 F2235200072 0 DT. 26.05.2022 NET WT: 5 ,794.78 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1684332 DT 26-MAY-2022 S/BIL L NO: 1684334 DT 26-MAY-2022 S/BILL NO: 1684337 DT 26-MAY-2 022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7497
KG
40
PKG
0
USD
MEDUM6393802
2021-03-10
613200 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 1 PALLET CONTAINING 15 C ARTONS PHARMACEUTI CALS AS UNDER APREPITANT CAPSULES 80MG 2UOU NDC CODE:6846205 8458 FDA PRODUCT CODE NO.: 61T C E 32 H. T. S NO.:30 04.90.92.40 ANDA NO. :20777 7 THERAPEUTICE USE:APREPIT ANT IS USEDWITH OTHER MED ICATIONS TO HELP PREVENT N AU SEA AND VOMITING CAUSED BY CANCER DRUG TREATM ENT ( CHEMOTHERAPY). THIS MEDICA TION IS ALSOUSED TO PREVE NT NAUSEA AND VOMITING AFT ER SURGERY.A-EMETIC/NAUSEA NT /HUMAN - RX/SINGLEINGR EDIENT / DELAYED RELEASE T ABLETS /APRE PITANT 1 DATA LOGGERS HUMIDITY:65% COMM ERCI AL & CUSTOM INVOICE NO . F20087001759 DT. 30.01.2 021 NET WT: 0.748 KGS FREIGHT PREPA ID THE TEM PERATURE TO BE SET AT 20 D EGREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCT ION S NAME ACCOUNT :GLENMARK PHARMACEUTICALS LIMITED<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
99
KG
1
PKG
0
USD
MAEU217387974
2022-04-27
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 3 PALLETS 54 CARTONS PHARMACEUTICAL S AS UNDER APREPITANT CAPSU LES 80MG 2UOU NDC CODE:684620 58458 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 T HERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND V OMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). TH IS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EMETIC/NAUS EANT / HUMAN - RX/SINGLE ING REDIENT / DELAYED RELEASE TAB LETS / APREPITANT NITROGLY CERIN SUBLING TABS 0.6MG 100 S NDC CODE:68462064001 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCI AL & CUSTOM INVOICE NO. F2228 7002071 DT. 30.03.2022 S/BILL NO: 4004810 DT: 31.03.2022 NET WT. 12.37 KGS 03 DATA LO GGERS NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
350
KG
3
PKG
0
USD
MAEU913326482
2021-12-02
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 5 P ALLETS CONSISTING OF 408 CARTO NS PHARMACEUTICALS AS UNDER APREPITANT CAPSULES 80MG 6UD NDC CODE:68462058476 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT APREPITANT CAPSULES 125MG 6UD NDC CODE:68462058576 NDC NO.:68462058576 FD A PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 THERAPEUTICE USE:APRE PITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUS ED BY CANCER DRUG TREATMEN T (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMIT ING AFTER SURGERY. A-EMETI C/NAUSEANT / HUMAN - RX/SI NGLE INGREDIENT / DELAYED RELEASE TABLETS / APRE PITANT ROSUVASTATIN TABLET S 10MG 90 S NDC CODE:68462026 290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 079172 THE RAPEUTICE USE: - TO TREAT HIG H CHOLESTEROL AND RELATED CON DITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE 05 DATA LO GGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. F22287001239 DT. 28.10.2021 F22287001277 DT. 01.11.2021 TOTAL GR.WT.:814.99KGS TOTAL NT.WT.:116.20KGS SBILL NO. DT. 4017276 28.10.2021 4017594 01.11.2021<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
815
KG
5
PKG
0
USD
MEDUMV866097
2020-10-06
613200 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 3 PALLETS CONTAINING 67 CA RTONS PHARMACEUTICALS AS U NDER DEFERASIROX TABS ORAL SUSP 500MG 30 S NDC CODE: 68462049630 FDA PRODUCT CO DE NO.: 63 J C A 09 H. T. S NO.: 3004.90.92.70ANDA NO.:209433 THERAPEUTICE US E:TREATMENT OF CHRONIC IRO N OVERLOAD DUE T
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
295
KG
3
PKG
0
USD
MEDUMA351748
2020-12-23
613200 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 5 PALLET CONTAINING 103 CARTONS PHARMACEUTIC ALS AS UNDER APREPITANT CAPSULES 80MG 2UOU NDC CODE:684620 58458 FDA PRODUCT CODE NO. : 61T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO. :20 7777 THERAPEUTICE USE:APRE PITANT IS USEDWITH OTHER MEDICATIONS TO HELP
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
784
KG
5
PKG
0
USD
MEDUMA441093
2020-12-30
613200 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 4 PALLET CONTAINING 108 C ARTONS PHARMACEUTI CALS AS UNDER APREPITANT CAPSULES 40MG 5UD NDC CODE:68462058 385 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 3 004.90.92.40 ANDA NO.:2077 77 THERAPEUTICE USE:APREPI TANT IS USEDWITH OTHER ME DICATIONS TO HEL
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
335
KG
4
PKG
0
USD
2021/201/C-2071882
2021-04-06
300410 SOUTH AMERICAN EXPRESS S A THEON PHARMACEUTICALS LIMITED AMOXCILINA THEON PHARMACEUTICALS; Medicaments (Excluding Goods Of Heading 30.02, 30.05 Or 30.06) Consisting Of Mixed Or Unmixed Products For Therapeutic Or Prophylatic Uses, Put Up In Measured Doses (Including Those In The Form Of Transdermal Administration System) Or In Forms Or Packings For Retail Sale, For Human Use
INDIA
BOLIVIA
JAWAHARLAL NEHRU (NHAVA SHEVA)
VERDE
1310
KG
1073
PIEZA/PAQUETE O TIPOS VARIADOS
5501
USD
2021/701/C-2265243
2021-10-29
283529 LABORATORIOS IFA S A JRS CHEMICALS PHARMACEUTICALS FOSFATO DE SODIO MONOBASICO ANHIDRO JRS CHE; Phosphinates (Hypophosphites), Phosphonates (Phosphites) And Phosphates, Polyphosphates, Whether Or Not Chemically Defined, Others
INDIA
BOLIVIA
JAWAHARLAL NEHRU (NHAVA SHEVA)
VERDE
28
KG
25
TAMBOR O BIDON
219
USD
MAEU218071767
2022-05-19
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 2 PALLETS 63 CART ONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:68462063 901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.: 206391 THE RAPEUTICE USE: MEDICATION USE D FOR HEART FAILURE, HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOIC E NO. F22387000104 DT. 22.04. 2022 S/BILL NO: 4005813 DT: 23.04.2022 NET WT: 33.11 KG S 02 DATA LOGGERS NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
395
KG
2
PKG
0
USD
KWLD70330048244
2021-05-05
662800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLINODUCT CODE NO. 66 S C A 28 H. T. S NO. 3004 .90.9020 ANDA NO.206391 THERAPEUTI . .<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
878
KG
4
PKG
0
USD
MEDUMV526246
2020-09-05
662800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 12 PALLETS CONTAINING 314 CARTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLI NG TABS 0.4MG 100 S NDC CO DE:68462063901 FDA PRODUCT CODE NO.:66 S C A 28 H. T . S NO.: 3004.90.9020ANDA NO.: 206391 THERAPEUTICE USE: MEDICATIO N USED FOR H EART FAILURE, HIG
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1994
KG
12
PKG
0
USD
MEDUM6438755
2021-03-13
662800 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 8 PALLET CONTAINING 130 CA RTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUB LING TABS 0.4MG 4X25 NDC C ODE:68462063945 FDA PRODUC T CODE NO.:66 S C A 28 H. T. S NO.:3004.90.9020 ANDA NO.:206391 THERAPEUTIC US E:MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESS URE,ANDTO TREAT AND PREVE NT CHEST PAIN FROM NOT EN O UGH BLOOD FLOW TO THE HEAR T APREPITANT CAPSULES 125 -80MG 3UOU NDC CODE:68462 011233 FDA PRODUCT CODE NO .:61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.:207 777 THERAPEUTICE USE:APREP ITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSE DBY CANCER DRUG TREATMENT (CHEMOTHERAPY). THI S MEDI CATION IS ALSO USED TO PRE VENT NAUSEA AND VOMITING A FTER SURGERY.A-EMETIC/NAUS EA NT /HUMAN - RX/SINGLE IN GREDIENT / DELAYED RELEASE TABLETS / APREPITANT 08 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGR EES COMMERCIAL & CUSTOM I NVOICE NO. F20087001803 DT . 05.02.2021 F20087001812 DT. 08.02.2021 NET WT: 45 .39 FREIGHT PREPAID T HE TEMPERATU RE TO BE SET A T 20 DEGREE CELCIUS IN ACC ORD ANCE WITH SHIPPER INSTR UCTIONS NAME ACCOUNT :GLE NMARK PHARMACEUTICALS LIMI TED ON BEHAL F OF GLENMARK PHARMACEUTICALS LIMITED<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1018
KG
8
PKG
0
USD
MEDUMG043570
2020-10-14
662800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 31 PALLETS CONTAINING 1362 CARTONS PHARMACEUTICALS A S UNDER NITROGLYCERIN SUBL ING TABS 0.4MG 4X25 NDC CO DE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC U SE: MEDICATION USED FOR HE ART FAILURE,HIG
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5751
KG
31
PKG
0
USD
MAEU217679666
2022-05-04
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 10 PALLETS 288 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TABS 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART APREPI TANT CAPSULES 40MG 1UD NDC CO DE:68462058340 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT NITROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:684620639 45 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.9 0.9020 ANDA NO.:206391 THERA PEUTIC USE: MEDICATION USED F OR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PRE VENT CHEST PAIN FROM NOT ENOU GH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TABS 0. 4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.:206391 THERAPE UTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART C OMMERCIAL & CUSTOM INVOICE NO. F22287002081 DT. 31.03.2022 F22287002106 DT. 31.03.2022 F22287002112 DT. 31.03.2022 F 22287002120 DT. 31.03.2022 S/ BILL NO:4004991 DT:04/04/2022 S/BILL NO: 4004990 DT:04/04/2 022 S/BILL NO:4004994 DT:04/0 4/2022 S/BILL NO: 4004995 DT: 04/04/2022 NET WT: 128.89 KG S 10 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2071
KG
10
PKG
0
USD
MEDUMG041822
2020-10-14
662800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 3 PALLETS CONTAINING 81 CA RTONS PHARMACEUTICALS AS U NDER NITROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE: 68462063945 FDA PRODUCT CO DE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA N O.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BL
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
614
KG
3
PKG
0
USD
MEDUMA708012
2021-01-21
662800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 5 PALLET CONTAINING 129 CA RTONS PHARMACEUTICALS AS UNDER AMLODIPINE-OLMESA RTAN TABS 10/20MG 90 S NDC CODE:68462056790 NITROGL YCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.:66 S C A 28 H. T. S NO.:3004.90 .9020 ANDA NO.:206391
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1051
KG
5
PKG
0
USD
MEDUMG877985
2020-12-02
662800 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 6 PALLET CONTAINING 199 CA RTONS PHARMACEUTICALS AS U NDER DEFERASIROX TABS ORAL SUSP 250MG 30 S NDC CODE: 68462049530 FDA PRODUCT CO DE NO.: 63 J C A 09 H. T. S NO.: 3004.90.92.70ANDA NO.:209433 THERAPEUTICE US E:TREATMENT OF CHRONIC IRO N OVERLOAD DUE T
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1063
KG
6
PKG
0
USD
MAEU218465385
2022-06-08
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 8 PALLETS 244 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TABS 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLY CERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART F AILURE,HIGH BLOOD PRESSURE,AN D TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FL OW TO THE HEART NITROGLYCE RIN SUBLING TABS 0.4MG 4X25 N DC CODE:68462063945 FDA PRODU CT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F22387000 165 DT. 30.04.2022 F223870001 69 DT. 30.04.2022 F2238700020 7 DT. 11.05.2022 S/BILL NO:40 06762 DT: 11.05.2022 S/BILL N O: 4006764 DT: 11.05.2022 S/B ILL NO: 4006766 DT: 11.05.2022 NET WT: 130.00 KGS 08 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1984
KG
8
PKG
0
USD
MAEU216355708
2022-03-02
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 07 PALLETS CONSISTING OF 197 C ARTONS PHARMACEUTICALS AS UN DER NITROGLYCERIN SUBLING TABS 0.6MG 100 S NDC CODE:68 462064001 FDA PRODUCT CODE N O.: 66 S C A 28 H. T. S NO .: 3004.90.9020 ANDA NO.:2 06391 THERAPEUTIC USE: MED ICATION USED FOR HEART FAILU RE,HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLO W TO THE HEART NITROGLYCER IN SUBLING TABS 0.4MG 100 S NDC CODE:68462063901 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEU TICE USE: MEDICATION USED FO R HEART FAILURE, HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TA BS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:2063 91 THERAPEUTIC USE: MEDICA TION USED FOR HEART FAILURE, HIGH BLOOD PRESSURE,AND TO T REAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW T O THE HEART 07 DATA LOGGER S COMMERCIAL & CUSTOM INVOICE NO. F22287001739 DT. 31.01.2022 F22287001740 DT. 31.01.2022 F22287001757 DT. 31.01.2022 SBILL NO. DT. 4001696 03. 02.2022 4001685 03.02.2 022 4001684 03.02.2022 TOTAL NET WT. 104.02KG S<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1285
KG
7
PKG
0
USD
MAEU214106776
2021-11-18
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REEFER PART OF FCL CONTAI NER 9 PALLETS CONSISTING OF 3 48 CARTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:684 62063901 FDA PRODUCT CODE NO. : 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: MEDICATIO N USED FOR HEART FAILURE, HIG H BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING T ABS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 30 04.90.9020 ANDA NO.:206391 T HERAPEUTIC USE: MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TABS 0.3MG 100 S NDC CODE:68462063 801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.:206391 THER APEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PR EVENT CHEST PAIN FROM NOT ENO UGH BLOOD FLOW TO THE HEART APREPITANT CAPSULES 40MG 5UD NDC CODE:68462058385 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT 09 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22287001201 DT. 21.10.2021 F 22287001202 DT. 21.10.2021 TO TAL GR.WT.: 1659.31KGS TOTAL NT.WT: 113.27KGS SBILL NOS DT 4016836 21.1 0.2021 4016835 21.10.2 021 NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. AVENUE L EOPOLD-ROBERT 37 LA CHAUX-D E-FONDS - 2300 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1659
KG
9
PKG
0
USD
MEDUMG700666
2020-11-24
621000 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 45 PALLET CONTAINING 2485 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAPSU LES 20MG 90 S NDC CODE:684 62039690 FDA PRODUCT CODE NO. :62KCF10 H. T. S NO.:30 04.90.9160 ANDA NO.: 91672 THERAPEUTICE USE TREATMEN T OF TREAT GASTROESOPHAGEA L REFLUX DISEAS
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
14962
KG
45
PKG
0
USD